ESAP

Indonesia

Bali
13 November 2014

Updates on Lung Cancer

With the assistance of the APSR Lung Cancer Assembly, and the hosted by the Indonesian Society of Respirology, this pre-congress ESAP took place in Bali, Indonesia, as a post-graduate course prior to the 19th Congress of the APSR.

Objectives:

Lung cancer is the leading cause of mortality of all cancer in the world. As two-thirds of smoking prevalence in the world is in the Asia-Pacific region, especially China, India and Indonesia, the prevalence of lung cancer in the region is increasing. The prevalence of lung cancer for nonsmokers and females is also increasing.

Pulmonologists and respiratory physicians play a key role in the diagnosis, staging and treatment of lung cancer. They also lead and participate in multidisciplinary efforts for lung cancer as well as managing comorbidities, provide medical treatment (chemotherapy and biological therapy), endobronchial treatment, general supportive care, and end-of-life care.

As the advancement of lung cancer biology and treatments is challenging, it is important to educate pulmonologists in the field. This ESAP presented updates on lung cancer biology, diagnosis and treatment.

Chairs:

Chair:	Dr Kwun Fong Professor University of Queensland Thoracic Research Centre at The Prince Charles Hospital Australia
Co-chair:	Dr Anwar Jusuf Professor Department of Pulmonology and Respiratory Medicine Faculty of Medicine, University of Indonesia Persahabatan Hospital, Jakarta, Indonesia

Speakers:

Dr E Hiyama (Japan)
Dr T Kikuchi (Japan)
Dr K Kishi (Japan)
Dr C Bai (China)
Dr D C L Lam (Hong Kong)
Dr B Robinson (Australia)
Dr C K Liam (Malaysia)
Dr K Hagiwara (Japan).

Attendees:

The event was well attended, including respiratory physicians, healthcare professionals and researchers from Australia, China, Hong Kong, Indonesia, Japan, Malaysia, Philipines, Republic of Korea, Singapore, and United Arab Emirates.

Programme

09.00–09.10	Course introduction Kwun Fong
09.10–09.35	Molecular diagnosis of lung cancer Eiso Hiyama
09.35–10.00	Lung cancer stem cell Toshiaki Kikuchi
10.00–10.25	Thoracic CT pattern in lung cancer: correlate on of CT and pathological diagnosis Kazuma Kishi
10.25–10.30	Discussion
10.30–11.00	Break
11.00–11.25	Genetic heterogeneity in lung cancer Koichi Hagiwara
11.25–11.50	The TNM staging system for lung cancer Kwun Fong
11.50–12.00	Discussion
12.00–13.00	Lunch
13.00–13.10	Summary of morning session Kwun Fong
13.10–13.35	Targeted agent in lung cancer: EGFR TKI and beyond David CL Lam
13.35–14.00	Lung tumour immunology Bruce Robinson
14.00–14.25	Neuroendocrine tumors of the lung Chong-Kin Liam
14.25–14.35	Discussion
14.35–15.00	Break
15.00–15.25	SCLC: what we have now Chunxue Bai
15.25–15.50	Lung cancer: the future ahead Koichi Hagiwara
15.50–16.00	Closing Postgraduate Course Kwun Fong